Evidence map›Paper›PMID 27381394›Full record

ArticleAntimicrobial agents and chemotherapy2016

The Lantibiotic NAI-107 Efficiently Rescues Drosophila melanogaster from Infection with Methicillin-Resistant Staphylococcus aureus USA300.

Thomas T Thomsen, Biljana Mojsoska, João C S Cruz, Stefano Donadio, Håvard Jenssen, Anders Løbner-Olesen, Kim Rewitz

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Frontiers in microbiology · 2024
    Review
  4. Infection and immunity · 2023
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Frontiers in microbiology · 2021
    Review
  10. Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Review
  11. Article
  12. Antimicrobial agents and chemotherapy · 2018
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Thomas T ThomsenDepartment of Biology, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-3130-2784
Biljana MojsoskaDepartment of Science, Systems and Models, Roskilde University, Roskilde, Denmark.
João C S CruzKtedogen, Milan, Italy.
Stefano DonadioKtedogen, Milan, Italy Naicons Srl, Milan, Italy.
Håvard JenssenDepartment of Science, Systems and Models, Roskilde University, Roskilde, Denmark.
Anders Løbner-OlesenDepartment of Biology, University of Copenhagen, Copenhagen, Denmark Lobner@bio.ku.dk Kim.Rewitz@bio.ku.dk.
Kim RewitzDepartment of Biology, University of Copenhagen, Copenhagen, Denmark Lobner@bio.ku.dk Kim.Rewitz@bio.ku.dk.
University of Copenhagen · DKRoskilde University · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We used the fruit fly Drosophila melanogaster as a cost-effective in vivo model to evaluate the efficacy of novel antibacterial peptides and peptoids for treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. A panel of peptides with known antibacterial activity in vitro and/or in vivo was tested in Drosophila Although most peptides and peptoids that were effective in vitro failed to rescue lethal effects of S. aureus infections in vivo, we found that two lantibiotics, nisin and NAI-107, rescued adult flies from fatal infections. Furthermore, NAI-107 rescued mortality of infection with the MRSA strain USA300 with an efficacy equivalent to that of vancomycin, a widely applied antibiotic for the treatment of serious MRSA infections. These results establish Drosophila as a useful model for in vivo drug evaluation of antibacterial peptides.

Indexed as

Amino Acid SequenceAnimalsAnti-Bacterial AgentsBacteriocinsDisease Models, AnimalDrosophila melanogasterMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsNisinStaphylococcal InfectionsSurvival AnalysisAnti-Bacterial AgentsBacteriocinsmicrobisporicinNisin

Identifiers

PMID27381394
PMCPMC4997821
OpenAlexW2460270757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.